Biologics And Biosimilars Taylor Francis Group by Taylor & Francis Group 9781138594227, 1138594229 instant download after payment.

Biologics and Biosimilars: Drug Development and Clinical Affairs is a systematic integration and evaluation of all aspects of biologics and biosimilars, R&D and clinical use, global regulation, and more. Biosimilars are biological therapeutic agents designed to imitate a reference biologics with high similarities in structure, efficacy and safety. Most of the top selling prescription drugs in the current market are biologics, which revolutionized the treatment strategies and modalities for life-threatening and rare diseases. This book outlines the key processes and challenges in drug development, regulations and clinical applications of biologics, biosimilars and bioequivalences. Professionals in the field discuss essential categories and prototype drugs of biologics and biosimilars in clinical practice including, allergenics, blood and blood components, cells, gene therapy, recombinant therapeutics proteins, tissues, and vaccines. Additional Features include: Integrates the latest bench and bed side evidences of drug development and regulations of biologics and biosimilars Features key study questions for each chapter to guide the reading as well as drug charts for all therapeutic applications of biologics and biosimilars Presents detailed schematic illustrations to explain the drug development, clinical trials, regulations and clinical applications of biologics and biosimilars This book is an invaluable tool for the pharmaceutical and health care industries, as well as the public. It both educates and updates the reader about the drug development and clinical affairs of biological medications and their similar drugs.